Drug record

Pravastatin: shortage, pharmacy cost, Medicare spending, recalls

What four public record sets show for pravastatin. Saved Nov 10, 2026.

RxPravastatinNov 10, 2026
ShortageNot on the FDA shortage listDetails
Pharmacy cost$0.057 each for the lowest-cost genericDetails
Medicare Part D, 2024$127.0 millionDetails
FDA recall records17Details
01

Shortage status

Whether the FDA lists this drug as in short supply.

Not on the FDA shortage list as of Nov 10, 2026.

The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.

02

What pharmacies pay

The national average price retail pharmacies pay to buy it (NADAC).

The lowest-cost generic on file is Pravastatin Sodium 20 Mg Tab: pharmacies pay about $0.057 each, or $1.70 for 30.

Product as surveyedTypePharmacy paysFor 30Price since
PRAVASTATIN SODIUM 10 MG TABGeneric$0.057 per each$1.72Oct 21, 2026
PRAVASTATIN SODIUM 20 MG TABGeneric$0.057 per each$1.70Oct 21, 2026
PRAVASTATIN SODIUM 40 MG TABGeneric$0.079 per each$2.37Oct 21, 2026
PRAVASTATIN SODIUM 80 MG TABGeneric$0.136 per each$4.09Oct 21, 2026

This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.

03

What Medicare spends

Medicare Part D spending by product, from the latest annual file (2024).

In 2024, Medicare Part D plans and their members paid $127.0 million for the 1 product below. That is down 42% from $217.5 million in 2020.

Product2024 spendingPeoplePer prescriptionPer person, year2020 spending
Pravastatin Sodium
Pravastatin Sodium
$127.0 million2,344,151$13.51$54.16$217.5 million

Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.

04

FDA recalls

Recalls reported to the FDA that name this drug.

The FDA has 17 recall records that name pravastatin in the product description (1 Class I · 14 Class II · 2 Class III). 6 are still marked ongoing.

Most recent 12

A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.

These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for pravastatin. This page is public-record information, not medical advice.